Uranyl, UO(2)(2+), was electrochemically determined by a phosphate based self-assembled monolayer. A pretreated gold electrode with 2-mercatpoethanol was chemically modified by POCl(3) or POBr(3) to obtain the surface phosphate active sites. The different stages were characterized by reflection-absorption Fourier transform-infrared (FT-IR) spectroscopy, capacity, and X-ray photoelectron spectroscopy (XPS). The electrochemical determination of UO(2)(2+) was accomplished, after preconcentration under open circuit potential, by square wave voltammetry.
No takes yet. Share an insight, caveat, or question.
Becker et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: